{"entity":{"type":"insider","cik":"0001554403","url":"/insider/0001554403","json_url":"/insider/0001554403.json","name":"Nash Christine A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":6,"first":"2014-01-14","last":"2015-03-17","span_basis":"filed_date"},"name_variants":[{"name":"Nash Christine A","source":"filing","n_filings":6,"first_seen":"2014-01-14","last_seen":"2015-03-17"}],"transactions":[{"id":8508732,"accession":"0001437749-15-005312","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-15-005312","line_url":"/filing/0001437749-15-005312#line-2","is_derivative":false,"issuer_cik":"0001386858","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001386858","owner_cik":"0001554403","owner_name":"Nash Christine A","owner_display_name":"Nash Christine A","owner_url":"/insider/0001554403","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":37.56,"price_display":"37.56","price_state":"stated","total_value":375600.0,"total_display":"375,600.00","total_whole":"375,600","shares_owned_after":19003.0,"shares_owned_after_display":"19,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-17","filed_date":"2015-03-17","scope":"insider"},{"id":8784727,"accession":"0001437749-15-004677","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-15-004677","line_url":"/filing/0001437749-15-004677#line-3","is_derivative":false,"issuer_cik":"0001386858","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001386858","owner_cik":"0001554403","owner_name":"Nash Christine A","owner_display_name":"Nash Christine A","owner_url":"/insider/0001554403","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1450.0,"shares_display":"1,450","price_per_share":30.1,"price_display":"30.10","price_state":"stated","total_value":43645.0,"total_display":"43,645.00","total_whole":"43,645","shares_owned_after":19003.0,"shares_owned_after_display":"19,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-10","filed_date":"2015-03-10","scope":"insider"},{"id":8428990,"accession":"0001437749-15-005080","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-15-005080","line_url":"/filing/0001437749-15-005080#line-2","is_derivative":false,"issuer_cik":"0001386858","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001386858","owner_cik":"0001554403","owner_name":"Nash Christine A","owner_display_name":"Nash Christine A","owner_url":"/insider/0001554403","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.08,"price_display":"35.08","price_state":"stated","total_value":350800.0,"total_display":"350,800.00","total_whole":"350,800","shares_owned_after":19003.0,"shares_owned_after_display":"19,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-10","filed_date":"2015-03-13","scope":"insider"},{"id":8784726,"accession":"0001437749-15-004677","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-15-004677","line_url":"/filing/0001437749-15-004677","is_derivative":false,"issuer_cik":"0001386858","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001386858","owner_cik":"0001554403","owner_name":"Nash Christine A","owner_display_name":"Nash Christine A","owner_url":"/insider/0001554403","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8450.0,"shares_display":"8,450","price_per_share":29.545325443786982,"price_display":"29.55","price_state":"stated","total_value":249658.0,"total_display":"249,658.00","total_whole":"249,658","shares_owned_after":23253.0,"shares_owned_after_display":"23,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-09","filed_date":"2015-03-10","scope":"insider","n_lines":2},{"id":8586794,"accession":"0001437749-15-001050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-15-001050","line_url":"/filing/0001437749-15-001050","is_derivative":false,"issuer_cik":"0001386858","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001386858","owner_cik":"0001554403","owner_name":"Nash Christine A","owner_display_name":"Nash Christine A","owner_url":"/insider/0001554403","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":24.815,"price_display":"24.82","price_state":"stated","total_value":124075.0,"total_display":"124,075.00","total_whole":"124,075","shares_owned_after":28903.0,"shares_owned_after_display":"28,903","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-20","filed_date":"2015-01-22","scope":"insider","n_lines":2},{"id":6927471,"accession":"0001123292-14-000301","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001123292-14-000301","line_url":"/filing/0001123292-14-000301","is_derivative":false,"issuer_cik":"0001386858","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001386858","owner_cik":"0001554403","owner_name":"Nash Christine A","owner_display_name":"Nash Christine A","owner_url":"/insider/0001554403","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5100.0,"shares_display":"5,100","price_per_share":29.04607843137255,"price_display":"29.05","price_state":"stated","total_value":148135.0,"total_display":"148,135.00","total_whole":"148,135","shares_owned_after":15098.0,"shares_owned_after_display":"15,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-06","filed_date":"2014-03-10","scope":"insider","n_lines":2},{"id":6545767,"accession":"0001123292-14-000119","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001123292-14-000119","line_url":"/filing/0001123292-14-000119#line-4","is_derivative":false,"issuer_cik":"0001386858","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001386858","owner_cik":"0001554403","owner_name":"Nash Christine A","owner_display_name":"Nash Christine A","owner_url":"/insider/0001554403","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":24.0108,"price_display":"24.01","price_state":"stated","total_value":26411.88,"total_display":"26,411.88","total_whole":"26,412","shares_owned_after":5098.0,"shares_owned_after_display":"5,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-14","filed_date":"2014-01-14","scope":"insider"},{"id":6545761,"accession":"0001123292-14-000119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-14-000119","line_url":"/filing/0001123292-14-000119#line-2","is_derivative":false,"issuer_cik":"0001386858","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001386858","owner_cik":"0001554403","owner_name":"Nash Christine A","owner_display_name":"Nash Christine A","owner_url":"/insider/0001554403","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8900.0,"shares_display":"8,900","price_per_share":24.0999,"price_display":"24.10","price_state":"stated","total_value":214489.11,"total_display":"214,489.11","total_whole":"214,489","shares_owned_after":98.0,"shares_owned_after_display":"98","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-10","filed_date":"2014-01-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001386858","name":"HYPERION THERAPEUTICS INC","url":"/issuer/0001386858","role":"Officer (SVP & Chief Commercial Officer)","n_filings":6,"first_seen":"2014-01-14","last_seen":"2015-03-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001554403","retrieved_at":"2026-08-22T17:12:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}